Data from the MASTER DAPT trial indicate that the duration of dual antiplatelet therapy can be abbreviated in patients at high risk of bleeding undergoing implantation of a drug-eluting stent, resulting in a reduction in bleeding risk without an increase in ischaemic events.

中文翻译：

---

缩写 DAPT 可降低出血风险

MASTER DAPT 试验的数据表明，对于接受药物洗脱支架植入的出血风险高的患者，双重抗血小板治疗的持续时间可以缩短，从而降低出血风险而不增加缺血事件。